1. Home
  2. CREV vs SCNI Comparison

CREV vs SCNI Comparison

Compare CREV & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carbon Revolution Public Limited

CREV

Carbon Revolution Public Limited

HOLD

Current Price

$0.40

Market Cap

3.1M

Sector

N/A

ML Signal

HOLD

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$0.80

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CREV
SCNI
Founded
2007
2003
Country
Australia
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CREV
SCNI
Price
$0.40
$0.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
53.2K
60.4K
Earning Date
01-30-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$47,677,475.00
$1,147,000.00
Revenue This Year
$40.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.03
Revenue Growth
86.77
303.87
52 Week Low
$0.36
$0.61
52 Week High
$9.20
$6.18

Technical Indicators

Market Signals
Indicator
CREV
SCNI
Relative Strength Index (RSI) 17.50 41.41
Support Level $1.58 $0.75
Resistance Level $1.65 $0.86
Average True Range (ATR) 0.11 0.09
MACD -0.09 -0.02
Stochastic Oscillator 2.87 13.87

Price Performance

Historical Comparison
CREV
SCNI

About CREV Carbon Revolution Public Limited

Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: